XML 55 R38.htm IDEA: XBRL DOCUMENT v3.24.3
Acquisition of Visimid Technologies (Details Narrative) - Acquisition of Visimid Technologies [Member] - USD ($)
1 Months Ended 12 Months Ended
Jan. 02, 2024
Oct. 23, 2023
Jul. 31, 2023
Jun. 30, 2024
Acquisition price of company in cash     $ 1,000,000  
Restricted stock       $ 1,550,000
Estimated fair values of the assets acquired and liabilities assumed       464,000
Bank debt     $ 150,000  
Description of restricted stock installments     Of the restricted stock payable as part of the purchase price, $150,000 (81,610 shares) was issued at closing, with the balance to be issued in four equal installments of $350,000 each, on January 1, 2024, July 1, 2024, January 1, 2025 and July 1, 2025  
Trade Secrets [Member]        
Estimated fair values of the assets acquired and liabilities assumed       925,000
Purchase price net acquisition cost       98,000
Trademarks [Member]        
Estimated fair values of the assets acquired and liabilities assumed       442,000
Customer Backlog [Member]        
Estimated fair values of the assets acquired and liabilities assumed       $ 150,000
Shares issued       267,176
Purchase price net acquisition cost       $ 2,700,000
Estimated useful lives of assets       1 year
Acquisition payment amount at the closing period $ 125,000 $ 150,000   $ 600,000
Customer Relationships [Member]        
Estimated fair values of the assets acquired and liabilities assumed       122,000
Purchase price net acquisition cost       $ 140,000
Estimated useful lives of assets       10 years